Emcure consolidates stake in Gennova, under stewardship of promoter family scion
Gennova is a ₹49-crore company and it mRNA business, at ₹6.47 crore, represented 0.71% of consolidated revenue of the company of ₹911.58 crore, Emcure said
Read the full articleYou might also wanna read
Emcure Pharmaceuticals buys final 12.05% Gennova stake for ₹231.87 Crore to consolidate control.
Emcure Pharmaceuticals is acquiring the remaining 12.05% stake in Gennova Biopharmaceuticals for ₹231.87 Crore to reach 100% ownership. This
Emcure Pharmaceuticals secures 100% control of Gennova with ₹231.87 crore final stake buy.
Emcure is acquiring the final 12.05% minority stake in Gennova for ₹231.87 crore, making it a 100% subsidiary. The move streamlines leadersh
Emcure Pharma to Invest ₹231.87 Crore to Acquire 100% Control of Gennova Biopharmaceuticals
Emcure Pharmaceuticals moves from 87.95% to 100% ownership of Gennova Biopharmaceuticals for ₹231.87 crore, simplifying its corporate struct
Emcure Pharma Q4 Net Profit Surges 24% to ₹243.74 Cr Ahead of Q1 Board Meet
Emcure Pharmaceuticals is preparing for its Q1 FY27 board meeting (date unverified) following a stellar Q4 FY26 performance where net profit
Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows
SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Ind
M. Q. Syed Bets Nearly Rs. 24 Crore on EXHICON Group's Listed Entity; Board Clears Preferential Allotment at Rs. 479 per Share
VMPL Mumbai (Maharashtra) [India], July 9: Exhicon Events Media Solutions Limited, a part of the EXHICON Group established in 1997 and India
Comments
Sign in to join the conversation.
No comments yet. Be the first.